Ryan Specialty Holdings, Inc. (NYSE:RYAN) Position Trimmed by Wells Fargo & Company MN

Wells Fargo & Company MN lowered its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 26.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 405,433 shares of the company's stock after selling 147,211 shares during the quarter. Wells Fargo & Company MN owned 0.15% of Ryan Specialty worth $26,013,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in RYAN. JPMorgan Chase & Co. lifted its stake in shares of Ryan Specialty by 107.5% in the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock valued at $30,504,000 after purchasing an additional 238,064 shares during the period. Bar Harbor Wealth Management lifted its position in shares of Ryan Specialty by 5.9% during the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock valued at $10,835,000 after acquiring an additional 9,482 shares during the period. Barclays PLC boosted its stake in shares of Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after acquiring an additional 17,267 shares in the last quarter. Teachers Retirement System of The State of Kentucky grew its holdings in shares of Ryan Specialty by 51.5% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company's stock worth $2,042,000 after acquiring an additional 10,460 shares during the period. Finally, HighTower Advisors LLC boosted its position in Ryan Specialty by 101.6% during the third quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock worth $2,661,000 after purchasing an additional 20,139 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on RYAN. UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Barclays decreased their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Wells Fargo & Company cut their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Finally, TD Cowen assumed coverage on Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $75.67.

Insider Buying and Selling

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00. Following the transaction, the director now owns 20,909 shares in the company, valued at $1,387,312.15. This represents a 62.60 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 176,894 shares of company stock worth $11,779,720 over the last quarter. 11.10% of the stock is owned by company insiders.

Ryan Specialty Stock Down 2.1 %

NYSE RYAN traded down $1.53 during mid-day trading on Thursday, reaching $70.56. 99,122 shares of the company's stock traded hands, compared to its average volume of 938,541. The company has a market cap of $18.48 billion, a price-to-earnings ratio of 102.25, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a fifty day simple moving average of $70.33 and a 200-day simple moving average of $68.99. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. As a group, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.